Dravet syndrome is a rare, severe form of epilepsy with symptoms that begin before a child turns 15 months old (and often within the first year of life). (1) Formerly known as severe myoclonic ...

Staff at Tiddlers Nursery in Coventry have been praised for the care and support they have provided to a two-year-old boy ...

"I dropped onto the sidewalk, my arms wrapped around my bent knees. 'Take him inside, don’t let him see me,' I blurted out.” ...

DUBLIN--(BUSINESS WIRE)--The "Dravet Syndrome Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This report outlays comprehensive insights of present clinical ...

PsychoGenics has signed on with Italy's Iama Therapeutics to run a preclinical study as part of an effort to identify and develop drug candidates to treat Dravet syndrome. Under the agreement, the U.S ...

Fenfluramine, a drug that was previously sold as an appetite suppressant before it was withdrawn from the market in 1997 over concerns about its link to heart valve problems, may have a new ...

LACKAWANNA COUNTY, Pa. — Seven-year-old Cael Hill of Roaring Brook just started kindergarten this year. "He is very into dinosaurs and Spider-Man. Your typical little boy in terms of his interests, ...

People who have Dravet syndrome, a rare and severe form of epilepsy, usually experience their first seizure within the first year of life. (1) These early seizures, which are typically triggered by a ...

LONDON--(BUSINESS WIRE)--The Dravet syndrome treatment market is set to grow by USD 396.15 million accelerating at a CAGR of over 9%, during the period spanning over 2020-2024. One of the key factors ...

A Solihull mum has praised a 'selfless' support worker who has become 'part of the family' after more than a decade of caring ...

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the ...